Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

It's dropped almost 40% this month alone (from $0.97 to $0.61). If news leaked of a patient death, that certainly would be a reason for sudden drop. And they wouldn't have to publicly disclose the patient death, only disclose it to the FDA. Then it's only a matter of time before the FDA puts the hold on, which would trigger a 3-day public disclosure by ADXS. I hope that's not what is happening, but the continuing collapse of the stock, silence by the company and no deal on either AXAL or HOT doesn't paint an optimistic picture.